These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 33111402)

  • 1. Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease.
    Tan MMX; Lawton MA; Jabbari E; Reynolds RH; Iwaki H; Blauwendraat C; Kanavou S; Pollard MI; Hubbard L; Malek N; Grosset KA; Marrinan SL; Bajaj N; Barker RA; Burn DJ; Bresner C; Foltynie T; Wood NW; Williams-Gray CH; Hardy J; Nalls MA; Singleton AB; Williams NM; Ben-Shlomo Y; Hu MTM; Grosset DG; Shoai M; Morris HR
    Mov Disord; 2021 Feb; 36(2):424-433. PubMed ID: 33111402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Parkinson's Disease Genome-Wide Association Study Locus Browser.
    Grenn FP; Kim JJ; Makarious MB; Iwaki H; Illarionova A; Brolin K; Kluss JH; Schumacher-Schuh AF; Leonard H; Faghri F; Billingsley K; Krohn L; Hall A; Diez-Fairen M; Periñán MT; Foo JN; Sandor C; Webber C; Fiske BK; Gibbs JR; Nalls MA; Singleton AB; Bandres-Ciga S; Reed X; Blauwendraat C;
    Mov Disord; 2020 Nov; 35(11):2056-2067. PubMed ID: 32864809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts.
    Iwaki H; Blauwendraat C; Leonard HL; Kim JJ; Liu G; Maple-Grødem J; Corvol JC; Pihlstrøm L; van Nimwegen M; Hutten SJ; Nguyen KH; Rick J; Eberly S; Faghri F; Auinger P; Scott KM; Wijeyekoon R; Van Deerlin VM; Hernandez DG; Gibbs JR; ; Chitrala KN; Day-Williams AG; Brice A; Alves G; Noyce AJ; Tysnes OB; Evans JR; Breen DP; Estrada K; Wegel CE; Danjou F; Simon DK; Andreassen O; Ravina B; Toft M; Heutink P; Bloem BR; Weintraub D; Barker RA; Williams-Gray CH; van de Warrenburg BP; Van Hilten JJ; Scherzer CR; Singleton AB; Nalls MA
    Mov Disord; 2019 Dec; 34(12):1839-1850. PubMed ID: 31505070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of PICALM with Cognitive Impairment in Parkinson's Disease.
    Periñán MT; Macías-García D; Labrador-Espinosa MÁ; Jesús S; Buiza-Rueda D; Adarmes-Gómez AD; Muñoz-Delgado L; Gómez-Garre P; Mir P
    Mov Disord; 2021 Jan; 36(1):118-123. PubMed ID: 32914893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele.
    Shahid M; Kim J; Leaver K; Hendershott T; Zhu D; Cholerton B; Henderson VW; Tian L; Poston KL
    Neurobiol Dis; 2019 Jul; 127():278-286. PubMed ID: 30826425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-Chromosome Association Study in Latin American Cohorts Identifies New Loci in Parkinson's Disease.
    Leal TP; Rao SC; French-Kwawu JN; Gouveia MH; Borda V; Bandres-Ciga S; Inca-Martinez M; Mason EA; Horimoto ARVR; Loesch DP; Sarihan EI; Cornejo-Olivas MR; Torres LE; Mazzetti-Soler PE; Cosentino C; Sarapura-Castro EH; Rivera-Valdivia A; Medina AC; Dieguez EM; Raggio VE; Lescano A; Tumas V; Borges V; Ferraz HB; Rieder CR; Schumacher Schuh A; Santos-Lobato BL; Velez-Pardo C; Jimenez-Del-Rio M; Lopera F; Moreno S; Chana-Cuevas P; Fernandez W; Arboleda G; Arboleda H; Arboleda Bustos CE; Yearout D; Barbosa MT; Cardoso FEC; Caramelli P; Cunningham MCQ; Maia DP; Lima-Costa MF; Tarazona-Santos E; Zabetian CP; ; Thornton TA; O'Connor TD; Mata IF;
    Mov Disord; 2023 Sep; 38(9):1625-1635. PubMed ID: 37469269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.
    Simuni T; Brumm MC; Uribe L; Caspell-Garcia C; Coffey CS; Siderowf A; Alcalay RN; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Nudelman K; Tosun-Turgut D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten S; Bressman S; Marek K;
    Mov Disord; 2020 May; 35(5):833-844. PubMed ID: 32073681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease.
    Fiorenzato E; Antonini A; Bisiacchi P; Weis L; Biundo R
    Mov Disord; 2021 Oct; 36(10):2303-2313. PubMed ID: 34124799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the LRP1B and APOE loci and the development of Parkinson's disease dementia.
    Real R; Martinez-Carrasco A; Reynolds RH; Lawton MA; Tan MMX; Shoai M; Corvol JC; Ryten M; Bresner C; Hubbard L; Brice A; Lesage S; Faouzi J; Elbaz A; Artaud F; Williams N; Hu MTM; Ben-Shlomo Y; Grosset DG; Hardy J; Morris HR
    Brain; 2023 May; 146(5):1873-1887. PubMed ID: 36348503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Genetic Drivers of Juvenile, Young, and Early-Onset Parkinson's Disease in India.
    Andrews SV; Kukkle PL; Menon R; Geetha TS; Goyal V; Kandadai RM; Kumar H; Borgohain R; Mukherjee A; Wadia PM; Yadav R; Desai S; Kumar N; Joshi D; Murugan S; Biswas A; Pal PK; Oliver M; Nair S; Kayalvizhi A; Samson PL; Deshmukh M; Bassi A; Sandeep C; Mandloi N; Davis OB; Roberts MA; Leto DE; Henry AG; Di Paolo G; Muthane U; Das SK; Peterson AS; Sandmann T; Gupta R; Ramprasad VL;
    Mov Disord; 2024 Feb; 39(2):339-349. PubMed ID: 38014556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E Genotype Contributes to Motor Progression in Parkinson's Disease.
    Pu JL; Jin CY; Wang ZX; Fang Y; Li YL; Xue NJ; Zheng R; Lin ZH; Yan YQ; Si XL; Chen Y; Liu Y; Song Z; Yan YP; Tian J; Yin XZ; Zhang BR
    Mov Disord; 2022 Jan; 37(1):196-200. PubMed ID: 34612548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease.
    Bartl M; Dakna M; Schade S; Otte B; Wicke T; Lang E; Starke M; Ebentheuer J; Weber S; Toischer K; Schnelle M; Sixel-Döring F; Trenkwalder C; Mollenhauer B
    Mov Disord; 2023 Jan; 38(1):68-81. PubMed ID: 36267007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson's disease.
    Senkevich K; Zorca CE; Dworkind A; Rudakou U; Somerville E; Yu E; Ermolaev A; Nikanorova D; Ahmad J; Ruskey JA; Asayesh F; Spiegelman D; Fahn S; Waters C; Monchi O; Dauvilliers Y; Dupré N; Greenbaum L; Hassin-Baer S; Grenn FP; Chiang MSR; Sardi SP; Vanderperre B; Blauwendraat C; Trempe JF; Fon EA; Durcan TM; Alcalay RN; Gan-Or Z
    Brain; 2023 May; 146(5):1859-1872. PubMed ID: 36370000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression.
    Chohan H; Senkevich K; Patel RK; Bestwick JP; Jacobs BM; Bandres Ciga S; Gan-Or Z; Noyce AJ
    Mov Disord; 2021 Jun; 36(6):1420-1429. PubMed ID: 33682937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal Polygenic Burden Drives Cognitive Decline in Parkinson's Disease with Low Alzheimer Risk.
    Tunold JA; Tan MMX; Toft M; Ross O; van de Berg WDJ; Pihlstrøm L
    Mov Disord; 2024 Mar; 39(3):596-601. PubMed ID: 38124396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD).
    Williams-Gray CH; Wijeyekoon R; Yarnall AJ; Lawson RA; Breen DP; Evans JR; Cummins GA; Duncan GW; Khoo TK; Burn DJ; Barker RA;
    Mov Disord; 2016 Jul; 31(7):995-1003. PubMed ID: 26999434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease.
    Davis MY; Johnson CO; Leverenz JB; Weintraub D; Trojanowski JQ; Chen-Plotkin A; Van Deerlin VM; Quinn JF; Chung KA; Peterson-Hiller AL; Rosenthal LS; Dawson TM; Albert MS; Goldman JG; Stebbins GT; Bernard B; Wszolek ZK; Ross OA; Dickson DW; Eidelberg D; Mattis PJ; Niethammer M; Yearout D; Hu SC; Cholerton BA; Smith M; Mata IF; Montine TJ; Edwards KL; Zabetian CP
    JAMA Neurol; 2016 Oct; 73(10):1217-1224. PubMed ID: 27571329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Ambulatory Capacity in Parkinson's Disease to Analyze Progression, Biomarkers, and Trial Design.
    Venuto CS; Smith G; Herbst K; Zielinski R; Yung NCW; Grosset DG; Dorsey ER; Kieburtz K
    Mov Disord; 2023 Oct; 38(10):1774-1785. PubMed ID: 37363815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease.
    Paul KC; Schulz J; Bronstein JM; Lill CM; Ritz BR
    JAMA Neurol; 2018 Mar; 75(3):360-366. PubMed ID: 29340614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Rare Variants in ARSA with Parkinson's Disease.
    Senkevich K; Beletskaia M; Dworkind A; Yu E; Ahmad J; Ruskey JA; Asayesh F; Spiegelman D; Fahn S; Waters C; Monchi O; Dauvilliers Y; Dupré N; Greenbaum L; Hassin-Baer S; Nagornov I; Tyurin A; Miliukhina I; Timofeeva A; Emelyanov A; Trempe JF; Zakharova E; Alcalay RN; Pchelina S; Gan-Or Z
    Mov Disord; 2023 Oct; 38(10):1806-1812. PubMed ID: 37381728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.